mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.7 |